Why is Titan Biotech falling/rising?

As of 06-Aug, Titan Biotech Ltd's stock price is currently at 472.30, reflecting a decline of 18.55 points or 3.78%. The stock has underperformed its sector by 3.87% today, following a trend reversal after three consecutive days of gains. It opened with a loss of 2% and reached an intraday low of Rs 462, which is a decrease of 5.88%. Despite this decline, there has been a notable increase in investor participation, with delivery volume rising by 515.32% against the 5-day average. The stock's performance over the past week shows an increase of 8.84%, but it has a year-to-date decline of 35.54%, indicating significant volatility and challenges in maintaining upward momentum.
In the broader market context, the Sensex has experienced a slight decline of 1.15% over the past week, while Titan Biotech's performance has been significantly better in that timeframe. However, the stock's year-to-date performance is considerably worse than the benchmark, which has gained 3.08%. This disparity highlights the challenges Titan Biotech faces in the current market environment, despite its strong performance over longer periods, such as a 401.91% increase over five years. The lack of available positive or negative factors further complicates the understanding of the stock's recent movements, leaving investors to interpret the current decline amidst a backdrop of mixed performance indicators.